Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers.
Na minha lista:
| Formato: | Article de revue numérique |
|---|---|
| Idioma: | Indéterminée |
| Publicado em: |
Journal of Visualized Experiments (JoVE)
2023.
|
| Acesso em linha: | Accès Université d'Orléans |
| Nota: |
JOVE Education |
| Variante du titre: | Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers |
Registos relacionados
-
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023 -
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023 -
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2023 -
Receptor Tyrosine Kinases.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2021 -
Receptor Tyrosine Kinases.
(Article de revue numérique)
Journal of Visualized Experiments (JoVE), 2022